Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-047187)

Filing Details

Accession Number:: 0001209191-15-047187
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-27 17:21:45
Reporting Period:: 2015-05-26

Filing Date:: 2015-05-27
Accepted Time:: 2015-05-27 17:21:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576263	Mirati Therapeutics Inc.	MRTX	Pharmaceutical Preparations (2834)	462693615

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1599324	Jamie Christensen	C/O Mirati Therapeutics, Inc. 9363 Towne Centre Drive, Suite 200 San Diego CA 92121	Svp & Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-05-26	4,750	$17.41	6,000	No	4	M	Direct
Common Stock	Disposition	2015-05-26	2,200	$28.11	3,800	No	4	S	Direct
Common Stock	Disposition	2015-05-26	2,550	$28.03	1,250	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-05-26	4,750	$0.00	4,750	$17.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
55,250		2024-05-20	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
15,000 shares subject to the Option vested and became exercisable on May 21, 2015, and 1,250 shares subject to the Option vest monthly thereafter.